Q3 2023
Released Nov 1, 2023, after the close
10-Q filed Nov 2, 2023, 33 days after period end · 0001653477-23-000057
Q3 2023 · 10-Q
Revenue$446.00M$446.00M −7.5% vs Q3 2022−7.4% vs Q2 2023
Net Income$25.20M$25.20M −66.6% vs Q3 2022−29.0% vs Q2 2023
EPS Diluted$0.69$0.69 −65.2% vs Q3 2022−28.9% vs Q2 2023
Gross Profit$129,000,000−26.8%
Operating Income$110,400,000−20.1%
Operating Cash Flowderived$105,200,000+5.1%
Free Cash Flowderived$71,700,000+12.0%
Margins · derived
Gross margin28.9%−7.7 pt vs Q3 2022
Operating margin24.8%−3.9 pt vs Q3 2022
Net margin5.7%−10.0 pt vs Q3 2022
What the release said
The release
Same quarter
| Metric | Q3 2023 | Q3 2022 | Q3 2021 | Q3 2020 |
|---|---|---|---|---|
| Revenue | $446.00M | $482.00M | $376.80M | $331.70M |
| Net Income | $25.20M | $75.40M | -$4.20M | $69.90M |
| EPS Diluted | $0.69 | $1.98 | -$0.11 | $1.69 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ingevity Corp · CIK 1653477 · Engraved from SEC EDGAR